Liberum Capital sees close to 80% upside to the current price for Ilika PLC (AIM:IKA, OTCQX:ILIKF) as the company advances its solid-state battery products.
The stockbroker’s ‘buy’ recommendation comes with a 245p price target (current price: 138p).
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) has received a buy recommendation and 195p target price from broker Berenberg, which has just started coverage of the liquid biopsy specialist.
The group’s Parsortix system extracts circulating tumour cells (CTCs) from blood with ease of use, sample quality and cost-effectiveness its strengths.
IXICO PLC (AIM:IXI, OTC:PHYOF) said Kate Rogers has joined as non-executive director and chair of the audit committee to replace John Bradshaw, who will be leaving the company in April.
Rogers currently leads the transformation of GlaxoSmithKline's (GSK) global finance organisation, having worked as chief financial officer for Laboratoire GlaxoSmithKline SaS (GSK France), and other senior finance roles within GSK.
88 Energy Ltd (AIM:88E, ASX:88E, OTC:EEENF) shares began trading on the OTCQB market in the United States, ahead of the expected spud of the explorer’s Alaskan well next month.
In a stock market statement, 88 Energy said the shares debuted on the OTCQB market on January 19, under the ticker code EEENF.
ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said pilot data from a study in ovarian cancer patients showed its Parsortix system could be used to select patients for clinical trials who are likely to respond better to immunotherapy treatments.
Andrew Newland, chief executive of ANGLE, said the data showcased the utility of the Parsortix system for the unbiased isolation of multiple subsets of circulating tumour cells (CTCs) in ovarian cancer patients.
Alien Metals Ltd has extended the completion date for its acquisition of a 30% interest in the Munni Munni platinum and gold project. A new completion date has been set for February 11.